Advisory Services Network’s Quince Therapeutics QNCX Stock Holding History

Advisory Services Network’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$558	Buy	+28	New	+$5.62K	﹤0.01%	4406
2025 Q4	–	Sell	-28	Closed	-$8.96K	–	3685
2025 Q3	$8.96K	Buy	+28	New	+$9.32K	﹤0.01%	3330
2024 Q1	–	Sell	-5	Closed	-$1.1K	–	3140
2023 Q4	$1.1K	Buy	+5	New	+$1K	﹤0.01%	3513
2023 Q2	–	Sell	-5	Closed	-$1.64K	–	3124
2023 Q1	$1.64K	Hold	5	–	–	﹤0.01%	3491
2022 Q4	$669	Buy	+5	New	+$836	﹤0.01%	3687
2021 Q3	–	Sell	-1	Closed	-$5K	–	2791
2021 Q2	$5K	Buy	+1	New	+$8.38K	﹤0.01%	3084
2021 Q1	–	Hold	0	–	-$1K	–	2563
2020 Q4	–	Hold	0	–	–	–	3177
2020 Q3	–	Hold	0	–	–	–	2991
2020 Q2	–	Hold	0	–	-$2K	–	2342
2020 Q1	–	Hold	0	–	–	–	2778
2019 Q4	–	Hold	0	–	–	–	2993

Other funds holding QNCX

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advisory Services Network's QNCX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Quince Therapeutics (QNCX) in Q1 2026: 28 shares worth $558. The stake represents ﹤0.01% of the portfolio and ranks #4406 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in QNCX as recently as Q3 2025.

Advisory Services Network first reported a position in QNCX in Q2 2021 and has held it in 6 quarters since. The position peaked at $8.96K in Q3 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

Advisory Services Network held 28 shares of Quince Therapeutics worth $558 as of Q1 2026.
Quince Therapeutics was a new Advisory Services Network position in Q1 2026.
Quince Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4406 holding.
Advisory Services Network first reported a position in Quince Therapeutics in Q2 2021 and has held it in 6 quarters since.
Advisory Services Network's Quince Therapeutics position peaked at $8.96K in Q3 2025.
43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.